NCT06318052View on ClinicalTrials.gov

The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Vaginal Atrophy Patients With GSM
Interventions
DEVICE

The FemTouch delivery system

The FemTouch delivery system is used in conjunction with the AcuPulse CO2 laser system and the AcuScan120 microscanner to provide fractional treatments in gynecology

DRUG

Gynomunal gel treatment

hormone/free, vaginal moisturizing gel for women with vaginal dryness

Trial Locations (1)

20255

RECRUITING

Frauenarztpraxis Heussweg, Hamburg

All Listed Sponsors
lead

Lumenis Be Ltd.

INDUSTRY

NCT06318052 - The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM) | Biotech Hunter | Biotech Hunter